[Advanced ovarian cancer: a need for redefining therapeutic objectives and strategy].
Bugat
Roland
R
Institut Claudius-Régaud, 20-24, rue du Pont St-Pierre, 31052 Toulouse. bugat@icr.fnclcc.fr
Guastalla
Jean-Paul
JP
Misset
Jean-Louis
JL
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019090:Case Management; D002986:Clinical Trials as Topic; D015897:Comorbidity; D019008:Drug Resistance, Neoplasm; D005260:Female; D005602:France / Q000453:epidemiology; D006040:Goals; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D010166:Palliative Care
D000970:Antineoplastic Agents